Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions

Jeannine M. Margolis and R. Scott Obach
Drug Metabolism and Disposition May 2003, 31 (5) 606-611; DOI: https://doi.org/10.1124/dmd.31.5.606
Jeannine M. Margolis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 5 606-611
DOI 
https://doi.org/10.1124/dmd.31.5.606
PubMed 
12695349

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 15, 2002
  • Accepted February 3, 2003
  • Published online May 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jeannine M. Margolis and
  2. R. Scott Obach
  1. Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut
  1. Dr. R. Scott Obach, MS 4088, Pfizer Global Research and Development, Groton, CT 06340. E-mail:obachrs{at}groton.pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2003 to February 2021

AbstractFullPdf
Apr 20038845178
May 200375122159
Jun 2003123669
Jul 2003212850
Aug 200391733
Sep 2003132329
Oct 2003153127
Nov 2003153033
Dec 2003142619
Jan 2004112540
Feb 2004123623
Mar 2004123940
Apr 2004112622
May 2004483566
Jun 2004213538
Jul 2004123160
Aug 2004223632
Sep 2004406231
Oct 2004245827
Nov 2004244929
Dec 2004274825
Jan 2005304337
Feb 2005193825
Mar 2005165249
Apr 200543628
May 200552530
Jun 200582840
Jul 2005122524
Aug 200562824
Sep 2005165233
Oct 2005102725
Nov 2005132735
Dec 200561916
Jan 200654019
Feb 2006114321
Mar 2006102516
Apr 200672424
May 200672016
Jun 200681816
Jul 2006101017
Aug 2006151723
Sep 200672918
Oct 200663121
Nov 200692624
Dec 20068139
Jan 2007123628
Feb 2007112114
Mar 200771620
Apr 200762616
May 200763119
Jun 200782817
Jul 2007122120
Aug 2007142021
Sep 200771211
Oct 2007151816
Nov 200791218
Dec 200711711
Jan 20085610
Feb 200891616
Mar 200831316
Apr 200811912
May 200871515
Jun 200841610
Jul 2008161718
Aug 2008111310
Sep 2008222815
Oct 2008172319
Nov 200881318
Dec 2008111112
Jan 200981215
Feb 2009101420
Mar 20098179
Apr 200941216
May 2009578
Jun 20096911
Jul 200941013
Aug 2009101421
Sep 2009101713
Oct 2009211011
Nov 2009161215
Dec 2009121614
Jan 201015613
Feb 20101468
Mar 201014711
Apr 201091210
May 201071310
Jun 20106169
Jul 2010121512
Aug 20105137
Sep 2010151710
Oct 20107155
Nov 2010102013
Dec 201015107
Jan 2011121513
Feb 201191511
Mar 2011201712
Apr 2011999
May 20111181
Jun 201111106
Jul 2011181616
Aug 2011151318
Sep 20111297
Oct 20119139
Nov 201115711
Dec 2011151411
Jan 201271417
Feb 2012171316
Mar 2012151018
Apr 201211816
May 201218812
Jun 2012131411
Jul 2012969
Aug 201210811
Sep 2012131013
Oct 2012211414
Nov 201271413
Dec 20125108
Jan 2013171321
Feb 201312610
Mar 20131267
Apr 201313915
May 20131686
Jun 20131137
Jul 20131156
Aug 20135104
Sep 20131558
Oct 201310613
Nov 2013782
Dec 20138310
Jan 2014614
Feb 201411711
Mar 20141448
Apr 201416129
May 2014899
Jun 2014869
Jul 201423712
Aug 20148915
Sep 201411917
Oct 201413717
Nov 201414616
Dec 2014141111
Jan 20156619
Feb 2015686
Mar 20158813
Apr 2015457
May 20151259
Jun 201514718
Jul 2015181614
Aug 20151256
Sep 20151278
Oct 20154138
Nov 20153410
Dec 20151126
Jan 201610513
Feb 2016238
Mar 20166323
Apr 20169521
May 201611119
Jun 2016328
Jul 20168712
Aug 2016445
Sep 2016989
Oct 20161199
Nov 201631812
Dec 20161127
Jan 201713111
Feb 2017084
Mar 20171103
Apr 20171165
May 201711812
Jun 2017197
Jul 20171147
Aug 201713017
Sep 201704511
Oct 20171795
Nov 20174307
Dec 20171107
Jan 20180177
Feb 20182117
Mar 20181339
Apr 201801712
May 201852713
Jun 20181175
Jul 201801616
Aug 20181134
Sep 20180213
Oct 201823216
Nov 201802710
Dec 2018191113
Jan 20191333
Feb 20194413
Mar 20191853
Apr 2019520
May 2019930
Jun 2019702
Jul 20193602
Aug 20192312
Sep 20194062
Oct 20191912
Nov 201920310
Dec 201935121
Jan 20202093
Feb 20201443
Mar 20204116
Apr 20203611
May 20201533
Jun 20202521
Jul 2020722
Aug 2020486
Sep 202031155
Oct 202020232
Nov 202012130
Dec 2020873
Jan 20217302
Feb 202111420

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (5)
Drug Metabolism and Disposition
Vol. 31, Issue 5
1 May 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions

Jeannine M. Margolis and R. Scott Obach
Drug Metabolism and Disposition May 1, 2003, 31 (5) 606-611; DOI: https://doi.org/10.1124/dmd.31.5.606

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions

Jeannine M. Margolis and R. Scott Obach
Drug Metabolism and Disposition May 1, 2003, 31 (5) 606-611; DOI: https://doi.org/10.1124/dmd.31.5.606
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics